Cowen analyst Yaron Werber raised the price target on Regeneron Pharma (NASDAQ: REGN) to $684.00 (from $584.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE